STOCKHOLDER'S EQUITY

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

STOCKHOLDER'S EQUITY

NOTE 9 – STOCKHOLDER’S EQUITY

Common Stock

There was no common stock activity during the three months ended March 31, 2019.

Warrants

The was no warrant activity for the three months ended March 31, 2019:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Life
Outstanding at December 31, 2018		46,201,477	$	0.08		1.9 Years
Outstanding at March 31, 2019		46,201,477	$	0.08		1.6 Years

Stock Options

The Company did not grant any stock options in the first three months of 2019. During the year ended December 31, 2018, the Company determined the grant date fair value of the options granted using the Black Scholes Method. The following assumptions were used in the year ended December 31, 2018:

Expected Volatility – 79-93%

Expected Term – 2.5 – 5.9 Years

Risk Free Rate – 2.4 – 3.0%

Dividend Rate – 0.00%

Activity related to stock options for the three months ended March 31, 2019 is summarized as follows:

			Weighted Average		Weighted Average
			Exercise		Contractual		Aggregate
	Number of Shares		Price		Term (Yrs.)		Intrinsic Value
Outstanding as of December 31, 2018		106,253,339	$	0.20		7.4	$	1,989,163
Granted		—		—
Forfeitures		—		—
Outstanding as of March 31, 2019		106,253,339		0.20		7.1	$	1,989,163
Exercisable as of March 31, 2019		97,165,278	$	0.20		7.1	$	1,886,038

The following table summarizes stock option information as of March 31, 2019:

				Weighted Average
				Contractual
Exercise Price		Outstanding		Life (Yrs.)		Exercisable
$	0.00001		3,500,000		6.5		3,500,000
	0.05		32,783,339		7.3		30,720,833
	0.10		27,200,000		7.5		25,811,111
	0.12		970,000		9.5		—
	0.13		250,000		8.6		83,333
	0.15		2,800,000		6.6		2,800,000
	0.22		2,750,000		8.8		750,000
	0.25		2,500,000		8.6		1,166,667
	0.26		500,000		9.1		—
	0.29		1,000,000		8.0		333,334
	0.40		1,000,000		6.9		1,000,000
	0.45		31,000,000		6.6		31,000,000
			106,253,339		7.1		97,165,278

During the three months ended March 31, 2019, the Company recognized approximately $349,000 of stock-based compensation expense related to options of which non-employees expense was approximately $75,000. As of March 31, 2019, there was approximately $1,049,000 of unrecognized compensation costs related to stock options outstanding of which approximately $184,000 was related to non-employees and will be expensed through 2022.